Jianzhijia Pharmaceutical Chain Group バランスシートの健全性
財務の健全性 基準チェック /36
Jianzhijia Pharmaceutical Chain Group has a total shareholder equity of CN¥2.8B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 118%. Its total assets and total liabilities are CN¥10.7B and CN¥7.9B respectively. Jianzhijia Pharmaceutical Chain Group's EBIT is CN¥449.3M making its interest coverage ratio 15.5. It has cash and short-term investments of CN¥760.6M.
主要情報
118.0%
負債資本比率
CN¥3.25b
負債
| インタレスト・カバレッジ・レシオ | 15.5x |
| 現金 | CN¥760.62m |
| エクイティ | CN¥2.76b |
| 負債合計 | CN¥7.95b |
| 総資産 | CN¥10.71b |
財務の健全性に関する最新情報
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt
Oct 03
Recent updates
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt
Oct 03What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?
Jul 16Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%
Jun 19Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet
Feb 27財務状況分析
短期負債: 605266's short term assets (CN¥4.7B) do not cover its short term liabilities (CN¥5.5B).
長期負債: 605266's short term assets (CN¥4.7B) exceed its long term liabilities (CN¥2.4B).
デット・ツー・エクイティの歴史と分析
負債レベル: 605266's net debt to equity ratio (90.4%) is considered high.
負債の削減: 605266's debt to equity ratio has increased from 12.9% to 118% over the past 5 years.
債務返済能力: 605266's debt is well covered by operating cash flow (25.1%).
インタレストカバレッジ: 605266's interest payments on its debt are well covered by EBIT (15.5x coverage).